跳至主要内容
临床试验/IRCT20200825048515N36
IRCT20200825048515N36招募中3 期

The Evaluation of the effect of atorvastatin in the prevention of gastrointestinal toxicity in patients undergoing pelvic radiotherapy

Esfahan University of Medical Sciences0 个研究点目标入组 64 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Pelvic radiotherapy indication due to gynecological, urological and lower gastrointestinal cancers.
  • At least 18 years old.
  • The total pelvic dose of patients during radiotherapy should be between 45-50 Gy.
  • Acceptable renal function and GFR> 60
  • Satisfaction to participate in the study

排除标准

  • Having a history of pelvic radiotherapy.
  • Having diabetes due to the possibility of intestinal disorders
  • Having an active liver or muscle disease
  • Having the contraindications to the use of statins
  • Having a serious physical or mental problem that prevents the completion of the course of treatment
  • Evidence of metastasis (having a performance status score greater than 70)
  • Taking cytochrome P450 3A4 inhibitors
  • Unwillingness to participate in the study

研究者

相似试验